Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Disease Areas › Infectious Disease › Mass Spec Test Developed to Distinguish Lyme Disease From Similar Condition

Mass Spec Test Developed to Distinguish Lyme Disease From Similar Condition

Aug 17, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Researchers led by Colorado State University have identified a new way to distinguish Lyme disease from similar conditions, a finding that could  lay the groundwork for other studies that could lead to better early testing for Lyme Disease, they said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Featured Webinar

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Featured Webinar

Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

What's Popular?

In Infectious Disease

  1. NIH Funds $33M in COVID-19 Testing Projects for Safe Return of Students, Staff to School

  2. FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

  3. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

  4. NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

  5. Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.